Skip to main content
. 2020 Oct 26;148(7):1625–1636. doi: 10.1002/ijc.33338

FIGURE 1.

FIGURE 1

Mendelian randomization estimates between (A) adiponectin, (B) leptin, (C) soluble leptin receptor and (D) plasminogen activator inhibitor‐1 concentrations and cancer risk using the inverse‐variance weighted method. CI, confidence interval; OR, odds ratio; PAI‐1, plasminogen activator inhibitor‐1; RCC, renal cell carcinoma; sOB‐R, soluble leptin receptor